Skip to content

Cancers & treatments

News & evidence

Living with cancer

Learn & contribute

Loading

A public, cited, editable map of oncology: technologies, targets, products, companies, institutions, pathways, trials, pairings, roadmaps, and ideas. One page per object, with a plain-language TL;DR on every page.

Work in progress. Every fact on this site is being built and checked in the open and may be incomplete, out of date, or wrong. You must do your own research and verify anything here at its primary source before relying on it. Nothing on this site is medical advice; decisions belong with you and your clinicians.

OnCo is an information resource, not medical advice. Nothing here replaces a conversation with a qualified clinician. Never delay care because of something you read here; in an emergency, call your local emergency services. Terms of use

Browse by cancer
Tags
Search
Connections
For me
Navigator
Biomarker matrix
Calculators
Interactions
Decision aids
Checkpoint side effects
Tumour board
Compare
Counts by category
Rankings
Timeline
Year by year
Query builder
Graph explorer
Saved
Body map

Cancers & treatments

News & evidence

Institutions & people

Institutions
Universities
Trial leadership
People
Heroes and heroines
Companies
Startups
Requests for startups
Investors
Company scorecards
Trial sponsors
Manufacturing map
Countries
United States deep dive
India deep dive
China deep dive
Germany deep dive
Israel deep dive
United Kingdom deep dive
Cases by country
Funding flows

Living with cancer

For me
The first 60 days
Appointment prep pack
Side effects
Symptom to test
Report reader
Survivorship planner
Second opinion
Financial help
Free in oncology
Paying for care in the US
NHS coverage
Paying for care in India
Coverage rankings
Cutting cancer care costs
Diet, exercise and lifestyle
Supportive care
Recovery and rejuvenation
Complementary and supportive approaches
Hair loss and regrowth
What comes back after treatment
Heroes and heroines

Learn & contribute

Reading paths
About & methodology
Roadmap
Gaps to fill
Coverage of the field
Review queue
Reviewer roster
Contributors
Idea votes
Teaching packs
Weekly issue
Suggest an edit
Answer quality
Data dictionary
Build on OnCo
Open API
Open data
Open tools
Open source in oncology
The software of oncology
GitHub

© 2026 OnCo. Code MIT. The data are free for individual and educational use with the attribution “Data from OnCo (onco.cc)”, under CC BY-NC 4.0. Commercial use must contact us to pay for the data. Commercial licences. Made with heart and soul by Jude Gomila .

About and methodology Corrections Open API Tags Terms of use Privacy policy GitHub

Loading

Home
Companies
Dong-A ST

companiesCompany

DA

Dong-A ST

Dong-A ST is a Seoul pharmaceutical company, the prescription-medicine arm of one of Korea's oldest drug groups, which sponsors phase 3 cancer trials including biosimilars and supportive-care products.

Also called: Dong-A ST Co., Ltd. · Dong-A Socio Holdings

Overview Connected3

Overview

Dong-A ST Co., Ltd. was formed in 2013 when the Dong-A group split its prescription business from its consumer arm. It develops and markets prescription medicines in Korea and abroad, including oncology supportive-care products, a pegylated G-CSF and biosimilars developed with partners, and it acts as lead sponsor of phase 3 cancer trials registered on ClinicalTrials.gov.

Headquarters

Seoul, KR

Type

Stage

Public

Website

www.donga-st.com

Founded

2013

Connected

Similar pages

Company
PregLem
Shares Pivotal (registrational) trial, Clinical trial.
Company
Agennix
Shares Pivotal (registrational) trial, Clinical trial.
Company
Lisata Therapeutics
Shares Pivotal (registrational) trial, Clinical trial.
Company
Immunitor
Shares Pivotal (registrational) trial, Clinical trial.
Company
Emergent BioSolutions
Shares Pivotal (registrational) trial, Clinical trial.
Company
Harbour BioMed
Shares Pivotal (registrational) trial, Clinical trial.
Company
Vion Pharmaceuticals
Shares Pivotal (registrational) trial, Clinical trial.
Company
Cyclacel Pharmaceuticals
Shares Pivotal (registrational) trial, Clinical trial.

terms

Clinical trial Pivotal (registrational) trial

trials

Clinical Trial to Investigate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of DA-4505 as a Single Agent and in Combination With Pembrolizumab in Adult Patients With Locally Advanced or Metastatic Solid Tumors

ProvenanceLast edited 2026-09-17 · Jude Gomila · Reverse links for orphaned trials · diff · file

Sources & links

Official website
ClinicalTrials.gov: trials led by Dong-A ST Co., Ltd.
Wikidata

Data

Follow this page

Wrong or missing?

Propose a change with a source. Organisations can update their own records. Every suggestion is reviewed, safety-checked and validated before it goes live; nothing is edited directly.

Suggest an editDiscuss start a thread

Out of date?
How review works

Terms

Pivotal (registrational) trial
Clinical trial

Trials

Clinical Trial to Investigate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of DA-4505 as a Single Agent and in Combination With Pembrolizumab in Adult Patients With Locally Advanced or Metastatic Solid Tumors

Not yet reviewedSee the review queue and roster.

Model panel commentary is coming to this page: machine commentary, not clinical review.

Machine-readable versions of Dong-A ST

JSON record with neighbours
Markdown context for language models
RDF Turtle for this record (its triples, relations and owl:sameAs; the IRI of this record is https://onco.cc/companies/dong-a-st/)
All companies as JSON
RDF N-Triples for the whole corpus
Search index: id, kind, name, TL;DR and route for every record
OpenAPI 3.1 description
API root and meta.json
llms.txt

MCP server: npx -y onco-mcp, tools search, get_entity, list_kind, ask, context, compare. This record is get_entity or context with id dong-a-st.

WebMCP tools registered on this page: onco_search, onco_get_entity.